Cisterna Analysis: $0.5M Raised
What is Cisterna?
Cisterna specializes in high-quality RNA products for biotechnology and medical research. Their proprietary technologies, such as SPEcific Capture and Cleavage, ensure exceptional purity and functionality. This commitment enables researchers to unlock the potential of RNA in various applications, including diagnostics and therapeutics.
HQ Country
Carlsbad, United States
Employees
1-10
Founded
2022
Industry
Biotech
Product Features & Capabilities
- HPLC-purified RNA with proprietary SPECC technology
- Off-the-shelf RNA products for immediate use
- Custom RNA synthesis tailored to specific research needs
- Advanced RNA purification methods eliminating impurities
- RNA solutions for diagnostics, immunology, and clinical applications.
How much Cisterna raised
1: - $500,000
August 22, 2022Lead Investor: Y Combinator, National Science Foundation
